Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Portfolio
Trending News
More News >
News
Enterprise Solutions
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Calculators
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
FDMT
Stock Latest News
The Fly
Biotech stocks slide as Marks resignation seen being negative for sector
17d ago
DYN
MGX
Premium
The Fly
BMO says Peter Marks resignation ‘significant negative’ for biotech
17d ago
MGX
BEAM
Premium
The Fly
4D Molecular price target lowered to $40 from $42 at BofA
1M ago
FDMT
Premium
The Fly
4D Molecular announces first patients enrolled in 4FRONT-1 Phase 3 trial
1M ago
FDMT
Premium
The Fly
4D Molecular price target lowered to $28 from $30 at Chardan
1M ago
FDMT
Premium
The Fly
4D Molecular price target lowered to $35 from $39 at RBC Capital
2M ago
FDMT
Premium
Ratings
Promising Developments in 4D Molecular Therapeutics’ Gene Therapy Program Justify Buy Rating
2M ago
FDMT
Premium
Company Announcements
4D Molecular Therapeutics Reports Strong Clinical Progress and Financial Position
2M ago
FDMT
Premium
Ratings
Optimistic Buy Rating for 4D-150 Driven by PRISM Study’s Promising Results in Treating Wet Age-Related Macular Degeneration
2M ago
FDMT
Premium
The Fly
4D Molecular price target lowered to $30 from $39 at Chardan
2M ago
FDMT
Premium
The Fly
4D Molecular’s wAMD drug is best-in-class, says RBC, sees ‘ideal’ entry point
2M ago
ADVM
FDMT
Premium
Ratings
Cautious ‘Hold’ Rating on 4D Molecular Therapeutics Amidst Competitive Market and Investor Concerns
2M ago
FDMT
Premium
Ratings
4D Molecular Therapeutics: Strong Buy Rating on Promising 4D-150 Gene Therapy Data and Strategic Phase 3 Trials
2M ago
FDMT
Premium
Ratings
Promising Prospects for 4D Molecular Therapeutics: Anticipated Growth in wAMD Treatment and Market Valuation
2M ago
FDMT
Premium
The Fly
4D Molecular price target lowered to $42 from $46 at BofA
3M ago
FDMT
Premium
The Fly
4D Molecular price target lowered to $6 from $8 at Morgan Stanley
3M ago
FDMT
Premium
The Fly
4D Molecular downgraded to Market Perform from Outperform at BMO Capital
3M ago
FDMT
Premium
The Fly
4D Molecular focuses pipeline to prioritize 4D-150 in wet AMD, DME
3M ago
FDMT
Premium
The Fly
4D Molecular announces interim data on 4D-150 SPECTRA clincial trial
3M ago
FDMT
Premium
The Fly
4D Molecular price target lowered to $46 from $79 at BofA
4M ago
FDMT
Premium
The Fly
4D Molecular announces publication of 4D-150 preclinical data
4M ago
FDMT
Premium
The Fly
4D Molecular initiated with an Underweight at Morgan Stanley
5M ago
FDMT
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >
You need to enable JavaScript to run this app.
